BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30572910)

  • 1. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
    Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
    BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a breast cancer risk assessment model in women with a positive family history.
    Bondy ML; Lustbader ED; Halabi S; Ross E; Vogel VG
    J Natl Cancer Inst; 1994 Apr; 86(8):620-5. PubMed ID: 8003106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
    Chay WY; Ong WS; Tan PH; Jie Leo NQ; Ho GH; Wong CS; Chia KS; Chow KY; Tan M; Ang P
    Breast Cancer Res; 2012 Jan; 14(1):R19. PubMed ID: 22289271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
    Rockhill B; Spiegelman D; Byrne C; Hunter DJ; Colditz GA
    J Natl Cancer Inst; 2001 Mar; 93(5):358-66. PubMed ID: 11238697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
    Tice JA; Cummings SR; Ziv E; Kerlikowske K
    Breast Cancer Res Treat; 2005 Nov; 94(2):115-22. PubMed ID: 16261410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
    Wang X; Huang Y; Li L; Dai H; Song F; Chen K
    Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Discrimination of Breast Cancer for Korean Women Based on Epidemiologic Data Only.
    Lee C; Lee JC; Park B; Bae J; Lim MH; Kang D; Yoo KY; Park SK; Kim Y; Kim S
    J Korean Med Sci; 2015 Aug; 30(8):1025-34. PubMed ID: 26240478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.
    Pastor-Barriuso R; Ascunce N; Ederra M; Erdozáin N; Murillo A; Alés-Martínez JE; Pollán M
    Breast Cancer Res Treat; 2013 Feb; 138(1):249-59. PubMed ID: 23378108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.